The University of Washington Population Health Initiative recently awarded 21 rapid response grants to study COVID-19. Four of these grants include faculty members from the Department of Global Health – Deepa Rao, Kristina Adams Waldorf, Bryan Weiner, and James Mullins.
by Ruanne Barnabas, Associate Professor, UW Global Health
The following links are a collection of news stories about the coronavirus that either quote, include, or were written by Department of Global Health faculty and staff. This includes video interviews with local and national media outlets, as well as written stories detailing DGH's research and innovation in fighting COVID-19.
Also see UW School of Public Health's web pages on Coronavirus Response, Resources and News
UW Researchers Study Effects of COVID-19 on Vulnerable Populations in Africa (Study led by Judd Walson)
As the global COVID-19 pandemic spreads, there are increasing numbers of cases in low- and middle-income country (LMIC) settings, including in many African countries. A new $1.38 million UW research project funded by the Bill and Melinda Gates Foundation will monitor the spread of COVID-19 in sites in Africa in order to increase understanding of the effects of COVID-19 on vulnerable children and adults, healthcare workers and researchers in low-resource settings.
UW to Lead National Study of Drug Promoted by President Trump to Fight Coronavirus (Seattle Times, Includes Ruanne Barnabas)
Researchers at the University of Washington on Friday announced a major new study of the malaria drug President Donald Trump has praised as a possible, low-cost cure for COVID-19.
The clinical trial is one of dozens around the world aimed at providing definitive evidence about the effectiveness of hydroxychloroquine, either alone or in combination with the antibiotic azithromycin, against the novel coronavirus.
Trial is looking at effectiveness of hydroxychloroquine with and without azithromycin. Results expected by July.
Researchers are now enrolling outpatients with COVID-19 for a randomized controlled trial of the effectiveness of two drug regimens – hydroxychloroquine and hydroxychloroquine with azithromycin.
Why There Isn’t a One-Size-Fits-All Plan for States to Reopen Their Economies (The Conversation, Q&A with Hilary Godwin)
In this Q&A, Hilary Godwin, dean of the University of Washington School of Public Health, explains why it makes sense for groups of states, such as Washington, Oregon and California, to coordinate their plans.
Governors are walking a tightrope as they try to figure out how to safely ease off social distancing restrictions and restart their economies without triggering a new surge in coronavirus cases.
Are our pets at risk for COVID-19?
Recent reports of animals testing positive for the novel coronavirus—including a cat in Belgium, a dog in Hong Kong and, famously, a tiger in the Bronx Zoo—have pet owners worrying about their furry companions. Many also wonder whether pets can pass COVID-19 on to people.
For graduating medical students, Match Day is the event that determines where they will spend the next years of their lives. On this day each year, students across the country learn where they will complete their residencies before obtaining medical licenses. Typically, this process happens in-person, with the graduating students able to celebrate the occasion with their loved ones. However, due to the circumstances surrounding the COVID-19 pandemic, this year’s Match Day took place virtually.
Experts at the UW Department of Global Health are actively engaged in COVID-19 research, learning, and service activities to help mitigate the global pandemic.
From testing patients and implementing measures to prevent outbreaks, to vaccine research, and prevention and treatment studies, our team is working to slow COVID-19.